Skip to main content
. 2022 Jun 6;2022(6):CD011574. doi: 10.1002/14651858.CD011574.pub2

25.4. Analysis.

25.4

Comparison 25: Sensitivity analysis 5, excluding studies with unclear or high risk of bias on incomplete outcome data, Outcome 4: Number of fallers ‐ cholinesterase inhibitor vs placebo